CYCS and Parkinson disease: Because the loss of cytochrome c-binding protein CHCHD2 destabilizes cytochrome c located between complex III and complex IV, leading to electron leakage and excessive oxidative stress, the compensation of respiratory complex I–IV activity seems to be a promising therapeutic target for PD.